Healthcare - Biotechnology - NASDAQ - CA
$ 0.595
0 %
$ 21.5 M
Market Cap
-2.05
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
--34.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BriaCell Therapeutics Corp.
BCTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BCTX
EBIT FORECAST
EBIT Forecast Chart BCTX
NET INCOME FORECAST
Net Income Chart BCTX